Pharmafile Logo
Pharmafocus logo
Advanced Search

Merck

Showing 15 posts of 363 posts found.

Merck signs Theravance cardio deal

October 19, 2012
Sales and Marketing Merck, Theravance, cardiovascular

Merck has signed a deal with US biopharma firm Theravance to discover and develop novel small molecules to treat cardiovascular …

News
Merck image

Merck enters €110m virus alliance

October 16, 2012
Research and Development, Sales and Marketing AiCuris, Gilead, HCMV, Merck

Merck has gained access to AiCuris’ portfolio of investigational medicines targeting human cytomegalovirus (HCMV) via a global licensing agreement. It …

News
Merck image

Merck gives back vernakalant rights

September 28, 2012
Sales and Marketing AF, Cardiome, Merck, vernakalant

Merck has dealt a further blow to Cardiome Pharma Corp by handing back all marketing and development rights for the …

News
Merck image

Merck releases new Phase III insomnia data

September 11, 2012
Research and Development, Sales and Marketing Merck, insomnia, suvorexant

Merck says it is on course to file its investigational insomnia drug suvorexant in the US by the end of …

News
Pfizer image

Pfizer meets targets on greenhouse gases

August 16, 2012
Manufacturing and Production GHGs, Merck, Pfizer

Pfizer says it has fulfilled its goal of cutting environmentally-harmful emissions from its facilities by 20%, a year ahead of …

News
merck_incweb

Merck’s Singulair faces generic rivals

August 7, 2012
Sales and Marketing Merck, Singulair, generic erosion, patent

Merck has lost patent protection on its biggest selling drug Singulair, opening the floodgates for generic rivals. Merck’s drug brought …

News
Merck image

Merck sees growth in second quarter

July 30, 2012
Sales and Marketing Cozaar, Merck, Q2, Singulair

Merck has posted a healthy sales increase for the second quarter, as its established drugs grew strongly. Sales increased 1% …

News
Merck image

Merck closes Cherokee Pharma plant

July 3, 2012
Manufacturing and Production API, Cherokee Pharmaceuticals, Merck, manufacturing

Merck & Co has decided to close down part of a US plant operated by subsidiary Cherokee Pharmaceuticals after failing …

News
Merck image

Merck’s sleep aid drug meets goals

June 15, 2012
Research and Development, Sales and Marketing FDA, Merck, insomnia, sleep disorder, suvorexant

Merck’s novel insomnia drug suvorexant has improved patients’ ability to fall asleep, according to new data from two Phase III …

News
Merck image

Merck extends biocatalysis collaboration with Codexis

May 29, 2012
Manufacturing and Production Codexis, Merck, Phil Taylor, Victrelis, manufacturing

Biocatalyst specialist Codexis has signed a three-year extension of its catalyst and process development collaboration with Merck to develop enzymes …

News
FDA picture

FDA approves greener process for Januvia production

May 1, 2012
Manufacturing and Production Codexis, FDA, Januvia, Merck, manufacturing

The US Food and Drug Administration (FDA) has approved a new, more environmentally-friendly manufacturing process for Merck & Co’s diabetes …

News

AstraZeneca diabetes drug recommended in Europe

April 23, 2012
Sales and Marketing AstraZeneca, CHMP, FDA, Merck, WHO, diabetes

AstraZeneca and Bristol-Myers Squibb’s new type II diabetes treatment Forxiga has received a positive opinion by European regulators.  The European …

News
Merck image

Merck does cancer drug deal with Endocyte

April 17, 2012
Research and Development, Sales and Marketing Cancer, Endocyte, Merck, NSCLC, vintafolide

Merck is to pay $120 million to US biopharma company Endocyte as part of a deal to develop and commercialise …

News
Merck image

Merck signs deal with venture capitalists

April 16, 2012
Research and Development, Sales and Marketing Flagship Ventures, Merck

Merck has entered a deal with a US venture capital firm specialising in life sciences to help build the manufacturer’s …

News

Januvia gains renal impairment licence in UK

April 13, 2012
Sales and Marketing Januvia, MSD, Merck, diabetes, renal impairment

Merck’s Januvia has had its licence extended in the UK for patients with moderate to severe renal impairment. The drug …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026